Medical Devices; Cardiovascular Devices; Classification of the Mechanical Deviation Device for Esophageal Protection During Cardiac Ablation Procedures
- Published
- Sep 10, 2026
- Effective
- Sep 10, 2026
- Citation
- 91 FR 57495
- Docket
- Docket No. FDA-2026-N-9905
- Agencies
- DEPARTMENT OF HEALTH AND HUMAN SERVICES, Food and Drug Administration
Final amendment; final order.
Summary
The Food and Drug Administration (FDA) has re‑classified the mechanical deviation device used to protect the esophagus during cardiac ablation procedures as a Class II medical device. Class II status means the device must meet specific “special controls”—such as performance standards, labeling requirements, and post‑market monitoring—to demonstrate safety and effectiveness. The FDA says this change balances patient safety with quicker access to innovative technologies by reducing the regulatory burden compared with a higher‑risk classification. The rule is issued by the U.S. Department of Health and Human Services, through the FDA, and it applies to manufacturers, distributors, and health‑care providers that develop, sell, or use these esophageal‑protection devices in the United States. By placing the device in Class II, the agency expects manufacturers to follow the identified special controls while still being able to market the product without the more extensive pre‑market approval process required for higher‑risk devices. The regulation was published in the Federal Register on September 10, 2026 (91 FR 57495) and took effect the same day. Because this is a final rule, the public comment period has already closed; the next steps involve manufacturers implementing the special‑control requirements and the FDA overseeing compliance through inspections and post‑market surveillance.
AI-generated summary — verify against the Federal Register text.
Official abstract
The Food and Drug Administration (FDA) is classifying the mechanical deviation device for esophageal protection during cardiac ablation procedures into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the mechanical deviation device for esophageal protection during cardiac ablation procedures. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believe this action will also enhance patients' access to beneficial innovative devices, in part by reducing regulatory burdens.
Topics
Track this rulemaking
Get alerts when this document changes status or its comment period closes, plus the bills that connect to it.
Sign up free